CIK 0001816736 · Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 851612845
- Phone
- (617) 674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,489,047
- in 7 filings, $12.6M under 10b5-1 plans
Net −$14,489,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | Khara Rahul Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 64,804 | ||
| 2025-01-02 | Khara Rahul Chief Legal Officer | Option exercise 10b5-1 | +7,500 | $14.69 | $110K | 21,535 |
| 2025-01-02 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −4,000 | $61.96 | $248K | 17,535 |
| 2025-01-02 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −1,400 | $62.95 | $88K | 16,135 |
| 2025-01-02 | Khara Rahul Chief Legal Officer | Sale 10b5-1 | −2,100 | $64.13 | $135K | 14,035 |
| 2025-01-02 | Khara Rahul Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,500 | 72,304 | ||
| 2024-12-31 | Quisel John D Chief Executive Officer | Option exercise 10b5-1 | +10,000 | $1.01 | $10K | 82,065 |
| 2024-12-31 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 215,420 | ||
| 2024-12-30 | Quisel John D Chief Executive Officer | Option exercise 10b5-1 | +13,012 | $9.86 | $128K | 85,077 |
| 2024-12-30 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −11,112 | $61.87 | $687K | 73,965 |
| 2024-12-30 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −1,900 | $62.41 | $119K | 72,065 |
| 2024-12-30 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,012 | 155,375 | ||
| 2024-12-23 | Quisel John D Chief Executive Officer | Option exercise 10b5-1 | +19,820 | $2.65 | $53K | 91,885 |
| 2024-12-23 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −3,414 | $62.38 | $213K | 88,471 |
| 2024-12-23 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −12,194 | $63.12 | $770K | 76,277 |
| 2024-12-23 | Quisel John D Chief Executive Officer | Sale 10b5-1 | −4,212 | $63.80 | $269K | 72,065 |
| 2024-12-23 | Quisel John D Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −19,820 | 41,830 |
Page 17 of 17 · 337 trades